208 related articles for article (PubMed ID: 11939847)
1. Rofecoxib vs celecoxib vs acetaminophen for treatment of osteoarthritis.
Bierma-Zeinstra SM; Bohnen AM; Berger MY; Thomas S
JAMA; 2002 Apr; 287(14):1799; author reply 1799-800. PubMed ID: 11939847
[No Abstract] [Full Text] [Related]
2. Rofecoxib vs celecoxib vs acetaminophen for treatment of osteoarthritis.
Henderson P
JAMA; 2002 Apr; 287(14):1799; author reply 1799-800. PubMed ID: 11939848
[No Abstract] [Full Text] [Related]
3. Efficacy of rofecoxib, celecoxib, and acetaminophen in osteoarthritis of the knee: a randomized trial.
Geba GP; Weaver AL; Polis AB; Dixon ME; Schnitzer TJ;
JAMA; 2002 Jan; 287(1):64-71. PubMed ID: 11754710
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of rofecoxib, celecoxib, and acetaminophen in patients with osteoarthritis of the knee. A combined analysis of the VACT studies.
Schnitzer TJ; Weaver AL; Polis AB; Petruschke RA; Geba GP;
J Rheumatol; 2005 Jun; 32(6):1093-105. PubMed ID: 15940774
[TBL] [Abstract][Full Text] [Related]
5. Selective COX-2 inhibitors.
Pasero C; McCaffery M
Am J Nurs; 2001 Apr; 101(4):55-6. PubMed ID: 11301685
[No Abstract] [Full Text] [Related]
6. [Cox-2 inhibitors in the focus. Rofecoxib as effective as the "classics"].
MMW Fortschr Med; 2001 Nov; 143(46):50-1. PubMed ID: 11759601
[No Abstract] [Full Text] [Related]
7. Pharmacological therapies for the treatment of osteoarthritis.
McColl GJ
Med J Aust; 2001 Nov; 175(S3):S108-11. PubMed ID: 11795556
[TBL] [Abstract][Full Text] [Related]
8. Clinical profiles of celecoxib and rofecoxib in the rheumatic diseases.
Gibofsky A
J Hypertens Suppl; 2002 Sep; 20(6):S25-30. PubMed ID: 12683424
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2--specific inhibitors and cardiorenal function: a randomized, controlled trial of celecoxib and rofecoxib in older hypertensive osteoarthritis patients.
Whelton A; Fort JG; Puma JA; Normandin D; Bello AE; Verburg KM;
Am J Ther; 2001; 8(2):85-95. PubMed ID: 11304662
[TBL] [Abstract][Full Text] [Related]
10. Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis.
Whelton A; White WB; Bello AE; Puma JA; Fort JG;
Am J Cardiol; 2002 Nov; 90(9):959-63. PubMed ID: 12398962
[TBL] [Abstract][Full Text] [Related]
11. [Side effects cause enormous costs. Expensive arthritis therapy].
MMW Fortschr Med; 2001 Nov; 143(46):60. PubMed ID: 11759607
[No Abstract] [Full Text] [Related]
12. Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol).
Graham GG; Graham RI; Day RO
Curr Pharm Des; 2002; 8(12):1063-75. PubMed ID: 11945151
[TBL] [Abstract][Full Text] [Related]
13. An observational, retrospective, cohort study of dosing patterns for rofecoxib and celecoxib in the treatment of arthritis.
Schnitzer TJ; Kong SX; Mitchell JH; Mavros P; Watson DJ; Pellissier JM; Straus WL
Clin Ther; 2003 Dec; 25(12):3162-72. PubMed ID: 14749154
[TBL] [Abstract][Full Text] [Related]
14. A model analysis of costs of blood pressure destabilization and edema associated with rofecoxib and celecoxib among older patients with osteoarthritis and hypertension in a Medicare Choice population.
Becker RV; Burke TA; McCoy MA; Trotter JP
Clin Ther; 2003 Feb; 25(2):647-62. PubMed ID: 12749519
[TBL] [Abstract][Full Text] [Related]
15. COX-2 inhibitors. Magic bullets or merely mortal?
Harv Health Lett; 2000 Feb; 25(4):4. PubMed ID: 10637015
[No Abstract] [Full Text] [Related]
16. Selective COX-2 inhibition.
Silas S; Clegg DO
Bull Rheum Dis; 1999; 48(2):1-4. PubMed ID: 12024416
[No Abstract] [Full Text] [Related]
17. Costs and effectiveness of rofecoxib, celecoxib, and acetaminophen for preventing pain after ambulatory otolaryngologic surgery.
Watcha MF; Issioui T; Klein KW; White PF
Anesth Analg; 2003 Apr; 96(4):987-994. PubMed ID: 12651647
[TBL] [Abstract][Full Text] [Related]
18. A clinical audit of the prescribing of celecoxib and rofecoxib in Australian rural general practice.
Cutts C; LaCaze A; Tett S
Br J Clin Pharmacol; 2002 Nov; 54(5):522-7. PubMed ID: 12445032
[TBL] [Abstract][Full Text] [Related]
19. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
[TBL] [Abstract][Full Text] [Related]
20. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
Zhao SZ; Wentworth C; Burke TA; Makuch RW
Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
